What are the anticipated absolute effects of Angiotensin receptor antagonist (ARB) versus placebo (CKD class 3b-4) on all-cause mortality?
The anticipated absolute effects of Angiotensin receptor antagonist (ARB) versus placebo (CKD class 3b-4) on all-cause mortality are from 32 fewer to 40 more, with a quality of evidence rated as VERY LOW due to risk of bias, imprecision.